» Articles » PMID: 36551474

Molecular Genetic Epidemiology of an Emerging Antimicrobial-Resistant Clone (ST307) Obtained from Clinical Isolates in Central Panama

Overview
Specialty Pharmacology
Date 2022 Dec 23
PMID 36551474
Authors
Affiliations
Soon will be listed here.
Abstract

Materials And Methods: We conducted an epidemiological study in three reference hospitals in the central region of Panama, using isolates of involved in infections, and identifying their AMR profile, associated clinical risk factors, and molecular typing using a multilocus sequence typing (ST) scheme.

Results: Six STs were detected: 307 (55%), 152, 18, 29, 405, and 207. CTX-M-15- and TEM-type beta-lactamases were identified in 100% of ESBL-producing strains; substitutions in Ser83Ile and parC Ser80Ile were identified in all ST307s; and in ST152 gyrA Ser83Phe, Asp87Ala, and parC Ser80Ile, the gene was detected in all strains resistant to ciprofloxacin.

Conclusions: We present the first report on ST307 in three reference hospitals in the central region of Panama, which is a high-risk emerging clone and represents a public health alert for potential difficulties in managing infections in Panama, and which may extend to other Central American countries.

Citing Articles

Phenotypic and Genotypic Profiles of Extended-Spectrum Beta-Lactamase-Producing Multidrug-Resistant in Northeastern Thailand.

Chaisaeng S, Phetburom N, Kasemsiri P, Putthanachote N, Wangnadee N, Boueroy P Antibiotics (Basel). 2024; 13(10).

PMID: 39452184 PMC: 11505529. DOI: 10.3390/antibiotics13100917.


Klebsiella pneumoniae with carbapenemases: high prevalence of sequence type 307 with bla in South African community hospitals.

Salvador-Oke K, Pitout J, Peirano G, Strydom K, Kingsburgh C, Ehlers M Eur J Clin Microbiol Infect Dis. 2024; 43(11):2239-2244.

PMID: 39289248 PMC: 11534848. DOI: 10.1007/s10096-024-04947-z.


Characterization of Carbapenemase- and ESBL-Producing Gram-Negative Bacilli Isolated from Patients with Urinary Tract and Bloodstream Infections.

Tickler I, Kawa D, Obradovich A, Fang F, Tenover F, The Healthcare Associated Infections Consortium Antibiotics (Basel). 2023; 12(9).

PMID: 37760683 PMC: 10525328. DOI: 10.3390/antibiotics12091386.

References
1.
Gonggrijp M, Santman-Berends I, Heuvelink A, Buter G, van Schaik G, Hage J . Prevalence and risk factors for extended-spectrum β-lactamase- and AmpC-producing Escherichia coli in dairy farms. J Dairy Sci. 2016; 99(11):9001-9013. DOI: 10.3168/jds.2016-11134. View

2.
Ghenea A, Cioboata R, Drocas A, tieranu E, Vasile C, Morosanu A . Prevalence and Antimicrobial Resistance of Strains Isolated from a County Hospital in Romania. Antibiotics (Basel). 2021; 10(7). PMC: 8300768. DOI: 10.3390/antibiotics10070868. View

3.
Ahmad Gogry F, Siddiqui M, Sultan I, Husain F, Al-Kheraif A, Ali A . Colistin Interaction and Surface Changes Associated with 1 Conferred Plasmid Mediated Resistance in and Strains. Pharmaceutics. 2022; 14(2). PMC: 8880236. DOI: 10.3390/pharmaceutics14020295. View

4.
Ocampo A, Chen L, Cienfuegos A, Roncancio G, Chavda K, Kreiswirth B . A Two-Year Surveillance in Five Colombian Tertiary Care Hospitals Reveals High Frequency of Non-CG258 Clones of Carbapenem-Resistant Klebsiella pneumoniae with Distinct Clinical Characteristics. Antimicrob Agents Chemother. 2015; 60(1):332-42. PMC: 4704171. DOI: 10.1128/AAC.01775-15. View

5.
Chong Y, Shimoda S, Shimono N . Current epidemiology, genetic evolution and clinical impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Genet Evol. 2018; 61:185-188. DOI: 10.1016/j.meegid.2018.04.005. View